- Clopidogrel in 20102010 | First Faculty of Medicine
- Clopidogrel in first-line doctor praxis2011 | First Faculty of Medicine, Third Faculty of Medicine
- The EUCLID Study (Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease)2018 | First Faculty of Medicine
- Acetylsalicylic acid and clopidogrel rezistance2006 | First Faculty of Medicine
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation2009 | First Faculty of Medicine
- Will clopidogrel aubstitute ticlopidin?2000 | First Faculty of Medicine
- The PRODIGY study: at last we know how to treat with clopidogrel after coronary angioplasty2011 | First Faculty of Medicine
- Clopidogrel - profile2001 | Second Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. D5135C00001 +1Publication without faculty affiliation
- News In contemporary management of acute coronary syndromes2014 | Faculty of Medicine in Pilsen
- Anti-platelet treatment: switching from clopidogrel to prasugrel2012 | Publication without faculty affiliation
- Clopidogrel and proton pump inhibitors +12009 | Faculty of Medicine in Hradec Králové
- Clopidogrel and proton pump inhibitors2009 | First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No: D5135C00001Publication without faculty affiliation
- Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures2009 | First Faculty of Medicine, Third Faculty of Medicine
- Clopidogrel Before Elective Percutaneous Coronary Intervention2010 | Third Faculty of Medicine
- Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation2020 | Third Faculty of Medicine
- Antiplatelet treatment with clopidogrel + ticlodipin in ad-hoc stentingPublication without faculty affiliation
- Clopidogrel is safer than ticagrelor in regard to bleeds: A closer look at the PLATO trial2013 | Second Faculty of Medicine
- Risk of combining clopidogrel with proton pump inhibitors - significance and possible solutions2010 | Third Faculty of Medicine
- Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel2013 | Second Faculty of Medicine
- Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on-chip capillary electrophoresis2012 | Third Faculty of Medicine
- CHARISMA - the clopidogrel for high atherotrombotic and ischemic stabilisation, management, and avoidance2006 | First Faculty of Medicine
- Renal Function, Assessed Using Cystatin C, and Antiplatelet Efficacy of Clopidogrel Assessed Using the Vasodilator-Stimulated Phosphoprotein Index in Patients Having Percutaneous Coronary Intervention2012 | Third Faculty of Medicine
- Antithrombotics in the prevention of cerebrovascular accidents: Part I - Significance of antiplatelet treatment2012 | First Faculty of Medicine, Third Faculty of Medicine
- Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?2015 | Second Faculty of Medicine
- Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease2013 | Third Faculty of Medicine